BIOMAT Database Logo BIOMAT Database Logo

Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis. 1990

M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Laboratoire de Génétique Moléculaire, Centre Hospitalier Universitaire Henri Mondor, Université Paris XII, Créteil, France.

The cystic fibrosis (CF) gene was recently identified as a gene spanning 250 kilobases (kbp) and coding for a 1480 amino acid protein, cystic fibrosis transmembrane conductance regulator (CFTR). Approximately 70% of CF mutations involve a three-base-pair deletion in CFTR exon 10, resulting in the loss of a phenylalanine at position 508 in the gene product (delta F508). In order to screen for other molecular defects, we have used a strategy based on denaturing gradient gel electrophoresis (DGGE) of polymerase chain reaction (PCR)-amplified gene segments. This method, which permits rapid detection of any sequence change in a given DNA stretch, was used successfully to analyse 61 non-delta F508 CF chromosomes from French CF patients. A study of CFTR exons 10, 11, 14a, 15 and 20 detected three mutations located in exons 14a, 15 and 20, along with several nucleotide sequence polymorphisms. These nucleotide changes were identified by direct sequencing of PCR fragments displaying altered electrophoretic behaviour, together with some of the polymorphisms and mutations previously characterized by others. The strategy presented here constitutes a valuable tool for the development of carrier testing for individuals or couples with a family history of cystic fibrosis, and will contribute to deciphering the functionally important regions of the CFTR gene.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006580 Genetic Carrier Screening Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE. Carriers, Genetic, Detection,Genetic Carriers, Detection,Heterozygote Detection,Carrier Detection, Genetic,Detection, Genetic Carrier,Genetic Carrier Detection,Heterozygote Screening,Carrier Screening, Genetic,Detection, Heterozygote,Screening, Genetic Carrier,Screening, Heterozygote,Screenings, Genetic Carrier
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Detection of p53 point mutations by double-gradient, denaturing gradient gel electrophoresis.
December 1997, Electrophoresis,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Optimized detection of DNA point mutations by double gradient denaturing gradient gel electrophoresis.
December 1998, Clinical chemistry and laboratory medicine,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
[Four novel point mutations of factor IX gene detected by denaturing gradient gel electrophoresis].
March 1998, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Detecting prion protein gene mutations by denaturing gradient gel electrophoresis.
January 1994, Human mutation,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
A simple method for identification of point mutations using denaturing gradient gel electrophoresis.
May 1993, Nucleic acids research,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Identification of the multiple beta-thalassemia mutations by denaturing gradient gel electrophoresis.
February 1990, The Journal of clinical investigation,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Detection of mutations by denaturing gradient gel electrophoresis.
May 2001, Current protocols in human genetics,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Use of denaturing gradient gel electrophoresis to detect point mutations in the factor VIII gene.
February 1990, Genomics,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Detection of mutations in insulin receptor gene by denaturing gradient gel electrophoresis.
April 1992, Diabetes,
M Vidaud, and P Fanen, and J Martin, and N Ghanem, and S Nicolas, and M Goossens
Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis.
January 1995, Human mutation,
Copied contents to your clipboard!